Wiley Blackwell

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Moskowitz
    Moskowitz
  3. Kumar
    Kumar
  4. Noy
    Noy
  5. Hamlin
    Hamlin
  6. Zelenetz
    Zelenetz
  7. Palomba
    Palomba
  8. Myskowski
    Myskowski
  9. Dogan
    Dogan
  10. Pulitzer
    Pulitzer

Groups

  1. Center for Hematologic Malignancies (54)
  2. Department of Medicine (54)
  3. Hematologic Malignancies, Division of (54)
  4. Lymphoma (54)
  5. Population Sciences Research Program (54)
  6. Sloan Kettering Institute Postdocs (15)
  7. Survivorship Research (15)
  8. Epidemiology and Biostatistics (12)
  9. Biostatistics Service (9)
  10. Dermatology Service (8)
Search Within
  1. "Steven Horwitz"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (17)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (54)
  2. Department of Medicine (54)
  3. Hematologic Malignancies, Division of (54)
  4. Lymphoma (54)
  5. Population Sciences Research Program (54)
  6. Sloan Kettering Institute Postdocs (15)

More Groups

People
  1. Steven Horwitz (54)
  2. Alison Moskowitz (20)
  3. Ahmet Dogan (14)
  4. David Straus (13)
  5. Anita Kumar (11)
  6. Ariela Noy (11)

More People

Years
  1. 2024 (1)
  2. 2023 (7)
  3. 2022 (2)
  4. 2021 (8)
  5. 2020 (2)
  6. 2019 (16)

More Years

Publications
  1. Hematological Oncology (38)
  2. Cancer (5)
  3. Breast Journal (2)
  4. Cancer Medicine (2)
  5. Cytometry Part B—Clinical Cytometry (2)
  6. Histopathology (2)

More Publications

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of flow cytometric immunophenotyping in the diagnosis of breast implant-associated anaplastic large cell lymphoma: A 6-year, single-institution experience
    Journal Article

    Chan, A.; Auclair, R.; Gao, Q.; Ghione, P.; Horwitz, S.; Dogan, A.; Roshal, M.; Lin, O.
    Cytometry Part B—Clinical Cytometry (2024)

    Fulltext@MSK | Save
  • Long term outcome of peripheral T cell lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network
    Meeting Abstract

    Civallero, M.; Advani, R.; Horwitz, S.; Manni, M.; Cabrera, M. E.; Vose, J.; Spina, M.; Hits, F.; Nagler, A.; Montoto, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: Outcomes by baseline histology
    Meeting Abstract

    Mehta‐Shah, N.; Jacobsen, E. D.; Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter‐Brown, L.; Izutsu, K.; Waters, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of 741 cases registered in the International Prospective T‐cell Project 2.0
    Meeting Abstract

    Manni, M.; Chiattone, C. S.; Prince, M. H.; Pavlovsky, A.; Tomuleasa, C.; Miranda, E.; Kriachok, I.; Hawkes, E. A.; Fiad, L.; Hitz, F.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • BRCA1/2 mutations impact on the development of breast implant‐associated lymphoma (BIA‐ALCL) in women with breast cancer reconstructed with textured breast implants
    Meeting Abstract

    Ghione, P.; Arcila, M.; Joseph, V.; Dogan, A.; Cordeiro, P.; Salles, G.; de Jong, D.; Horwitz, S.; Mandelker, D.; van Leeuwen, F.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • AFM13 in patients with CD30 positive relapsed or refractory (R/R) peripheral T cell lymphoma (PTCL): Results from the phase 2 redirect study
    Meeting Abstract

    Kim, W. S.; Shortt, J.; Zinzani, P. L.; Mikhaylova, N.; Marin‐Niebla, A.; Radeski, D.; Ribrag, V.; Domenech, E. D.; Sawas, A.; Alexis, K.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective International T-cell lymphoma project
    Journal Article

    Chiattone, C.; Civallero, M.; Fischer, T.; Miranda, E.; Manni, M.; Zing, N. P. C.; Pileri, S. A.; Montoto, S.; Horwitz, S. M.; Cabrera, M. E.; more...
    Hematological Oncology (2022)

    Fulltext@MSK | Save
  • PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome
    Journal Article

    Lewis, N. E.; Gao, Q.; Petrova-Drus, K.; Pulitzer, M.; Sigler, A.; Baik, J.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Cytometry Part B—Clinical Cytometry (2022)

    Fulltext@MSK | Save